Spectral Medical Stock
Spectral Medical Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- Canada
- CEO
- Chris Seto
- Employees
- 29
- Market cap
- $314 M
- IPO
- 13/08/1996
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative…
Spectral Medical stock: price history
1D
-2.7%
1W
-3.6%
1M
-15.1%
6M
-23.0%
YTD
-25.7%
1Y
-32.7%
2Y
+81.4%
5Y
+234.4%
10Y
+256.7%
Next earnings date
Next earnings date
06/11/2026 (in 20 days)
Volatility around earnings
~27% weaker price swings than usual
Ask the agents about Spectral Medical
Spectral Medical stock metrics
P/E
-8.32
P/B
-4.48
EV/EBITDA
-10.47
RETURN ON EQUITY
-0.5%
NET MARGIN
53.3%
DEBT/EQUITY
-0.37
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
70.5%
FLOAT SHARES
206,864,549
AVG. DAILY VOLUME (30D)
50,922
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Spectral Medical stock
What does Spectral Medical do?
Spectral Medical Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in Canada.
The CEO is Chris Seto, the company employs around 29 people.
The IPO was on 13/08/1996; the stock trades on TSX under the ticker EDT.TO.
When does Spectral Medical report next?
The next earnings date is 06/11/2026.
Around past earnings, price swings were roughly -27% stronger than usual.
Does Spectral Medical pay a dividend?
Yes. The last dividend was CA$0.12 per share.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Spectral Medical?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Spectral Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Spectral Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.